Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.17%.

  • United Therapeutics' Return on Invested Capital rose 100.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.16% for FY2024, which is 0.0% changed from last year.
  • United Therapeutics' Return on Invested Capital amounted to 0.17% in Q3 2025, which was up 100.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Return on Invested Capital ranged from a high of 0.18% in Q1 2022 and a low of 0.09% during Q1 2021
  • Over the past 5 years, United Therapeutics' median Return on Invested Capital value was 0.16% (recorded in 2024), while the average stood at 0.15%.
  • Per our database at Business Quant, United Therapeutics' Return on Invested Capital tumbled by -800bps in 2021 and then skyrocketed by 900bps in 2022.
  • Quarter analysis of 5 years shows United Therapeutics' Return on Invested Capital stood at 0.11% in 2021, then soared by 40bps to 0.16% in 2022, then fell by -8bps to 0.15% in 2023, then rose by 9bps to 0.16% in 2024, then rose by 3bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.16% for Q2 2025, and 0.16% during Q1 2025.